Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pharmaceutical statistics

Showing results (31-40 of 1,234) with videos related to

Pageof 124
Sort By:
Pharmaceutical Statistics|November 26, 2015
Practical guide to sample size calculations: non-inferiority and equivalence trialsLaura Flight, Steven A Julious
Pharmaceutical Statistics|September 30, 2016
Estimating the reliability of repeatedly measured endpoints based on linear mixed-effects models. A tutorialWim Van der Elst, Geert Molenberghs, Ralf-Dieter Hilgers, et al.
Pharmaceutical Statistics|September 12, 2019
A two-stage phase II clinical trial design with nested criteria for early stopping and efficacyMichelle DeVeaux, Michael Kane, Wei Wei, et al.
Pharmaceutical Statistics|February 23, 2019
Design of experiments and the virtual PCR simulator: An online game for pharmaceutical scientists and biotechnologistsHarold Fellermann, Ben Shirt-Ediss, Jerzy Kozyra, et al.
Pharmaceutical Statistics|February 23, 2021
Optimising the trade-off between type I and II error rates in the Bayesian contextRosalind J Walley, Andrew P Grieve
Pharmaceutical Statistics|February 17, 2017
Statistical issues in first-in-human studies on BIA 10-2474: Neglected comparison of protocol against practiceSheila M Bird, Rosemary A Bailey, Andrew P Grieve, et al.
Pharmaceutical Statistics|March 16, 2017
Addressing potential prior-data conflict when using informative priors in proof-of-concept studiesTimothy Mutsvari, Dominique Tytgat, Rosalind Walley
Pharmaceutical Statistics|September 10, 2019
Bayesian sample-size determination methods considering both worthwhileness and unpromisingness for exploratory two-arm randomized clinical trials with binary endpointsTomoyuki Kakizume, Fanghong Zhang, Yohei Kawasaki, et al.
Pharmaceutical Statistics|January 30, 2007
What is the logic in mixing data and beliefs?Paul M Brown
Pharmaceutical Statistics|April 5, 2008
Consequences of dichotomizationValerii Fedorov, Frank Mannino, Rongmei Zhang
Pageof 124

Showing results (31-40 of 1,234) with videos related to

Sort By:
Pageof 124
Pharmaceutical Statistics|November 26, 2015
Practical guide to sample size calculations: non-inferiority and equivalence trialsLaura Flight, Steven A Julious
Pharmaceutical Statistics|September 30, 2016
Estimating the reliability of repeatedly measured endpoints based on linear mixed-effects models. A tutorialWim Van der Elst, Geert Molenberghs, Ralf-Dieter Hilgers, et al.
Pharmaceutical Statistics|September 12, 2019
A two-stage phase II clinical trial design with nested criteria for early stopping and efficacyMichelle DeVeaux, Michael Kane, Wei Wei, et al.
Pharmaceutical Statistics|February 23, 2019
Design of experiments and the virtual PCR simulator: An online game for pharmaceutical scientists and biotechnologistsHarold Fellermann, Ben Shirt-Ediss, Jerzy Kozyra, et al.
Pharmaceutical Statistics|February 23, 2021
Optimising the trade-off between type I and II error rates in the Bayesian contextRosalind J Walley, Andrew P Grieve
Pharmaceutical Statistics|February 17, 2017
Statistical issues in first-in-human studies on BIA 10-2474: Neglected comparison of protocol against practiceSheila M Bird, Rosemary A Bailey, Andrew P Grieve, et al.
Pharmaceutical Statistics|March 16, 2017
Addressing potential prior-data conflict when using informative priors in proof-of-concept studiesTimothy Mutsvari, Dominique Tytgat, Rosalind Walley
Pharmaceutical Statistics|September 10, 2019
Bayesian sample-size determination methods considering both worthwhileness and unpromisingness for exploratory two-arm randomized clinical trials with binary endpointsTomoyuki Kakizume, Fanghong Zhang, Yohei Kawasaki, et al.
Pharmaceutical Statistics|January 30, 2007
What is the logic in mixing data and beliefs?Paul M Brown
Pharmaceutical Statistics|April 5, 2008
Consequences of dichotomizationValerii Fedorov, Frank Mannino, Rongmei Zhang
Pageof 124